Moreover, the therapeutic efficacy of inducible anti‐tumor proteins (PNFAT‐p53+PNF6‐DAPK3) was comparable to that of the constitutive group (PCMV‐p53), indicating that the timing of LVs injection did not affect the therapeutic efficacy (Figure S11, Supporting Information). This evidence concerns the gene DAPK3 and neoplasm.